leading glp-1 treatments for diabetes 2025 What is the pipeline future medications for obesity? GLP-1 Pipeline Update: November 2025

Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice

When 503A or 503B compounding pharmacies prepare tirzepatide formulations for patients, they frequently add cyanocobalamin or methylcobalamin to the vial

Currently, it is only FDA-approved for the treatment of type 2 diabetes, but is being studied for the treatment of obesity, as it was seen to cause significant weight loss

The result is smoother, firmer, and more youthful-looking skin

They also need to wait 30 minutes before they can eat or drink more

Probiotics : Early research suggests that probioticslive microorganisms in your digestive systemmay promote cells in the intestines to secrete GLP-1, thus improving insulin function